Oncovision (GEM Imaging SA) specializes in innovative medical imaging technologies aimed at enhancing the diagnosis and treatment of cancer. Their flagship products include Mammi, a Breast PET imaging system designed for precise breast cancer detection, and Sentinella, which offers advanced imaging capabilities to locate sentinel lymph nodes during cancer surgeries. Additionally, Wprobe is a practical and user-friendly tool that aids in the accurate identification of tumors, while CareMiBrain focuses on innovative solutions for Alzheimer's disease, showcasing the company's commitment to addressing critical healthcare challenges through advanced imaging techniques.

The company's mission emphasizes the transformation of medical practices through early cancer diagnosis using molecular imaging technologies. Oncovision aims to set a new standard in diagnostic testing and treatment, providing both clinical and economic benefits. Their dedication to research and innovation is supported by various investment initiatives, including backing from Innvierte and the Generalitat Valenciana, which underscores their role as a key player in the medical imaging market and their goal of improving patient quality of life and healthcare professionals' experiences.

Spain

Oncovision is a healthcare technology company that specializes in medical imaging for cancer detection.

Oncovision (GEM Imaging SA)

Company Details